Nuove ricerche sulla Sindrome da sospensione
Psychother Psychosom. 2024 Jul 23:1-6. doi: 10.1159/000540031. Online ahead of print.Selective Serotonin Reuptake Inhibitor and Serotonin-Noradrenaline Reuptake Inhibitor Withdrawal Changes DSM Presentation of Mental Disorders: Results from the Diagnostic Clinical Interview for Drug WithdrawalFiammetta Cosci 1 2 3, Virginie-Anne Chouinard 4, Guy Chouinard 5 
Research PaperThe nature and impact of antidepressant withdrawal symptoms and proposal of the Discriminatory Antidepressant Withdrawal Symptoms Scale (DAWSS)Joanna Moncrieff (1, 2), John Read (3), Mark Horowitz (1, 2)Department of Psychiatry, University College London, London, UK Goodmayes Hospital, North East London NHS Foundation Trust, London, UK School of Psychology, University of
A seguito del documentario di BBC Panorama "The Antidepressant Story" (link) che ha trattato il problema della sindrome da sospensione di antidepressivi SSRI/SNRI e la PSSD, è stata firmata da numerosi professionisti della sanità una lettera indirizzata al Servizio sanitario nazionale del Regno Unito (NIH): "Il governo ha il dovere morale di aiutare chi è stato danneggiato da farmaci prescritti".
Australian Journal of General Practice, Volume 50, Issue 12, December 2021Antidepressant prescribing in general practice: A call to actionKatharine A Wallis Maria Donald Joanna Moncrieff doi: 10.31128/AJGP-02-21-5828The Mental health: Productivity Commission inquiry report (2020) recommended as a ‘priority reform’ that we ‘[a]ddress adverse
Adele Framer - SurvivingAntidepressants.org, San Francisco, California, USAFirst Published March 16, 2021 Review Article https://doi.org/10.1177/2045125321991274Corresponding Author: survivingads@gmail.comAbstractAlthough psychiatric drug withdrawal syndromes have been recognized since the 1950s – recent studies confirm antidepressant withdrawal syndrome incidence upwards of 40% – medical
Michael P. Hengartner, Lukas Schulthess, Anders Sorensen, Adele FramerFirst Published December 24, 2020 Research Articlehttps://doi.org/10.1177/2045125320980573This article is part of the following special collection(s): Discontinuing Psychotropic MedicationCorresponding Author: heng@zhaw.chAbstractBackground:Protracted withdrawal syndrome (PWS) after stopping antidepressants (frequently also
Psychother Psychosom. 2020 Apr 7:1-24. doi: 10.1159/000506868. [Epub ahead of print]
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications.
Cosci F1,2, Chouinard G3.
1
Department of Health Sciences, University of Florence, Florence, Italy, fiammetta.cosci@unifi.it.
2
Department of Psychiatry and Neuropsychology, Maastricht University,
Epidemiol Psychiatr Sci.2019 Aug 22:1-3. doi: 10.1017/S2045796019000465. [Epub ahead of print]
Antidepressant withdrawal - the tide is finally turning.
Hengartner MP1,Davies J2,3,;Read J4,5.
Author information
1
Department of Applied Psychology, Zurich University of Applied Sciences, Zurich, Switzerland.
2
Department of Life Sciences, University of Roehampton, London, UK.
3
Lancet Psychiatry.2019 Jun;6(6):538-546. doi: 10.1016/S2215-0366(19)30032-X. Epub 2019 Mar 5.
Tapering of SSRI treatment to mitigate withdrawal symptoms.
Horowitz MA1,Taylor D2.
Author information
1
Prince of Wales Hospital, Sydney, NSW, Australia; Health and Environment Action Lab, London, UK. Electronic address: mark_horo@hotmail.com.
2
Institute of Pharmaceutical Science, King's
NICE guidance on depression: 35 health organisations demand “full and proper” revision
BMJ2019;365doi:https://doi.org/10.1136/bmj.l2356(Published 28 May 2019)Cite this as:BMJ2019;365:l2356
Jacqui Wise (London)
A coalition of health bodies has met with the National Institute for Health and Care Excellence (NICE) to call for a “full and proper revision” of its 2009 guideline on adult
BMJ2019;365doi:https://doi.org/10.1136/bmj.l2238 (Published 20 May 2019)Cite this as:BMJ2019;365:l2238James Davies, reader1,
John Read, professor2,
Michael P Hengartner, senior lecturer3,
Fiammetta Cosci, associate professor4,
Giovanni Fava, professor5,
Guy Chouinard, professor6,
Jim van Os, professor7,
Antonio Nardi, professor8,
Peter Gøtzsche, professor9,
Peter Groot,
Addict Behav. 2019 Oct;97:111-121. doi: 10.1016/j.addbeh.2018.08.027. Epub 2018 Sep 4.
A
systematic review into the incidence, severity and duration of
antidepressant withdrawal effects: Are guidelines evidence-based?
Davies J1, Read J2.
Author information
1
University
of Roehampton, London, United Kingdom; All-Party Parliamentary Group
for Prescribed Drug Dependence, United
Int J Risk Saf Med. 2018;29(3-4):175-180. doi: 10.3233/JRS-180018.SSRI and SNRI withdrawal symptoms reported on an internet forum.
Stockmann T1, Odegbaro D2, Timimi S3, Moncrieff J4.
Author information
1 NELFT NHS Foundation Trust, Division of Psychiatry, University College London, UK.
2 Northampton Healthcare NHS Foundation Trust, Northampton, UK.
3 Faculty of Health and Social
Riv Psichiatr. 2018 Mar-Apr;53(2):95-99. doi: 10.1708/2891.29158.
The Diagnostic clinical Interview for Drug Withdrawal 1 (DID-W1) –New Symptoms of Selective Serotonin Reuptake Inhibitors (SSRI)or Serotonin Norepinephrine Reuptake Inhibitors (SNRI):inter-rater reliability
Cosci F1, Chouinard G2, Chouinard VA3, Fava GA4.
1
Department
of Health Sciences, University of Florence, Italy -
Psychother Psychosom. 2015 Feb 21;84(2):72-81. [Epub ahead of print]
Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review.
Autori: Fava GA, Gatti A, Belaise C, Guidi J, Offidani E.
Sintomi da Sospensione dopo l'interruzione degli Inibitori Selettivi della Ricaptazione della Serotonina: Una Revisione Sistematica.
Abstract
Background:
Psychother Psychosom. 2012;81(6):386-8. doi: 10.1159/000341178. Epub 2012 Sep 6.
Patient Online Report of Selective Serotonin Reuptake Inhibitor-Induced Persistent Postwithdrawal Anxiety and Mood Disorders
Ansia
e disturbi dell'umore come sintomi persistenti emergenti dalla Sindrome
da Sospensione da Inibitori Selettivi della Ricaptazione della
Serotonina (SSRIs): studio condotto sulle